K. K. Laktionov - N.N. Blokhin National Medical Research Center of Oncology", Federal State Budgetary Institution

基本信息

浏览量：36

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 101 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Durvalumab with or Without Tremelimumab in Combination with Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes from the Phase 3 POSEIDON Trial

Solange Peters,Byoung Chul Cho,Alexander V. Luft,Jorge Alatorre-Alexander,Sarayut Lucien Geater,Konstantin Laktionov,Dmytro Trukhin,Sang-We Kim, Grygorii M. Ursol,Maen Hussein,Farah Louise Lim,Cheng-Ta Yang,Luiz Henrique Araujo,Haruhiro Saito,Niels Reinmuth, Caitlin Lowery,Helen Mann,Ross Stewart,Haiyi Jiang,Edward B. Garon,Tony Mok, Melissa L. Johnson

JOURNAL OF THORACIC ONCOLOGYno. 1 (2025): 76-93

引用1浏览0WOS引用

Molecular Residual Disease Analysis of Adjuvant Osimertinib in Resected EGFR-mutated Stage IB-IIIA Non-Small-cell Lung Cancer

Nature medicineno. 6 (2025): 1958-1968

引用0浏览0WOSNATURE引用

A Plain Language Summary of Results from the FLAURA2 Study: Initial (First-Line) Osimertinib Treatment with or Without Chemotherapy in Patients with Untreated EGFR-mutated Advanced NSCLC

David Planchard,Pasi A Jänne,Ying Cheng,James Chih-Hsin Yang,Noriko Yanagitani,Sang-We Kim,Shunichi Sugawara,Yan Yu,Yun Fan,Sarayut Lucien Geater,Konstantin Laktionov,Chee Khoon Lee,Natalia Valdiviezo,Samreen Ahmed, Jean-Marc Maurel, Igor Andrasina,Jonathan Goldman,Dana Ghiorghiu,Yuri Rukazenkov, Alex Todd,Kunihiko Kobayashi

Future oncology (London, England)no. 8 (2025): 903-915

引用0浏览0WOS引用

A Plain Language Summary of Results from the FLAURA2 Study: Effects of Initial (First-Line) Osimertinib Plus Chemotherapy on the Brain in Patients with EGFR-mutated Advanced Non-Small Cell Lung Cancer

Pasi A Jänne,David Planchard,Kunihiko Kobayashi,Ying Cheng,Chee Khoon Lee,Natalia Valdiviezo,Konstantin Laktionov,Tsung-Ying Yang,Yan Yu,Terufumi Kato,Liyan Jiang,Busyamas Chewaskulyong,Sarayut Lucien Geater, Jean-Marc Maurel, Carlos Rojas,Toshiaki Takahashi,Frances A Shepherd,Kentaro Tanaka,Dana Ghiorghiu, Neha P Amin, Elena Armenteros-Monterroso, Xiangning Huang, Ammar Ahmed Chaudhry,James Chih-Hsin Yang

Future oncology (London, England)no. 8 (2025): 917-928

引用0浏览0WOS引用

Durvalumab Versus Chemotherapy As First-line Treatment for Metastatic NSCLC with Tumor PD-L1 Expression ≥25%: Results from the Randomized Phase 3 PEARL Study

Shun Lu,Lin Wu,Qiming Wang,Ziping Wang,Dongqing Lv,Rui Ma,Bo Zhu,Ngoc van Tran,Liyan Jiang,Kejun Nan,Konstantin Laktionov,Stephen Clarke, Minghao Song,Helen Mann, Yinglei Liu,Xiaojin Shi,Yi-Long Wu

Journal of Thoracic Oncology (2024)

引用0浏览0WOS引用

ADRIATIC: Durvalumab (D) As Consolidation Treatment (tx) for Patients (pts) with Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

David R. Spigel,Ying Cheng,Byoung Chul Cho,Konstantin K. Laktionov,Jian Fang,Yuanbin Chen,Yoshitaka Zenke,Ki Hyeong Lee,Qiming Wang,Alejandro Navarro,Reyes Bernabe Caro, Eva Lotte Buchmeier,John W. C. Chang,Isamu Okamoto,Sema Sezgin Goksu,Andrzej Badzio,Bethany Gill,Hema Gowda,Haiyi Jiang,Suresh Senan

JOURNAL OF CLINICAL ONCOLOGYno. 17_SUPPL (2024)

引用7浏览0引用

Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Non-Small Cell Lung Cancer with PD-L1 ≥ 1 %: A Subgroup Analysis from the EMPOWER-Lung 3 Part 2 Trial

Ana Baramidze,Tamta Makharadze,Miranda Gogishvili,Tamar Melkadze,Davit Giorgadze,Konstantin Penkov,Konstantin Laktionov,Gia Nemsadze,Marina Nechaeva,Irina Rozhkova,Ewa Kalinka,Debra A. G. McIntyre, Javier Perez,Manika Kaul,Ruben G. W. Quek,Frank Seebach,Petra Rietschel,Jean-Francois Pouliot

LUNG CANCER (2024)

引用1浏览0WOS引用

Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer

Ying Cheng,David R. Spigel,Byoung Chul Cho,Konstantin K. Laktionov,Jian Fang,Yuanbin Chen,Yoshitaka Zenke,Ki Hyeong Lee,Qiming Wang,Alejandro Navarro,Reyes Bernabe, Eva Lotte Buchmeier, John Wen-Cheng Chang,Yoshimasa Shiraishi,Sema Sezgin Goksu,Andrzej Badzio, Anhui Shi,Davey B. Daniel,Nguyen Thi Thai Hoa,Milada Zemanova,Helen Mann,Hema Gowda,Haiyi Jiang,Suresh Senan

NEW ENGLAND JOURNAL OF MEDICINE（2024）

引用12浏览0WOS引用

Possibilities of Liquid Biopsy in Determining the Mechanisms of Resistance to Osimertinib

Константин Константинович Лактионов,Елена Валерьевна Реутова, Ирина Анатольевна Демидова,Федор Владимирович Моисеенко, Артур Евгеньевич Горохов, Алексей Андреевич Баринов, Екатерина Олеговна Степанова

Voprosy onkologiino. 2 (2024): 324-329

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn